Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer|March 17, 2007
Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphomaDavid J Straus, Madeleine Duvic, Timothy Kuzel, et al.
Leukemia & Lymphoma|October 30, 2004
A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL)Chadi Nabhan, David Patton, Leo I Gordon, et al.
Journal of the American Academy of Dermatology|October 5, 2010
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphomaYoun H Kim, Michael Girardi, Madeleine Duvic, et al.
Biomed Research International|October 28, 2015
Single-Fraction Radiotherapy for CD30(+) Lymphoproliferative DisordersMichelle S Gentile, Maria Estela Martinez-Escala, Tarita O Thomas, et al.
Photodermatology, Photoimmunology & Photomedicine|September 14, 2012
Long-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresisRobert Knobler, Madeleine Duvic, Christiane Querfeld, et al.
European Urology|August 25, 2022
First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-GuérinKhyati Meghani, Lauren Folgosa Cooley, Bonnie Choy, et al.
Cancer Research|March 9, 2005
Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancerQiang Zhang, Ximing Yang, Michael Pins, et al.
Molecular Cancer Therapeutics|August 8, 2006
Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycleQiang Zhang, Ximing J Yang, Shilajit D Kundu, et al.
Cancer Reports (Hoboken, N.J.)|September 4, 2020
Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic centerElizabeth Elliott, Virginia Speare, James Coggan, et al.
Journal for Immunotherapy of Cancer|July 27, 2024
Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohortSandip P Patel, Megan Othus, Young Kwang Chae, et al.
Pageof 3